Suppr超能文献

时空聚类分析检测创新临床实践:以退伍军人事务部阿立哌唑为例。

Space-Time Cluster Analysis to Detect Innovative Clinical Practices: A Case Study of Aripiprazole in the Department of Veterans Affairs.

机构信息

Group Health Research Institute, Seattle, WA.

Department of Health Services Research, School of Public Health, University of Washington, Seattle, WA.

出版信息

Health Serv Res. 2018 Feb;53(1):214-235. doi: 10.1111/1475-6773.12639. Epub 2016 Dec 22.

Abstract

OBJECTIVE

To identify space-time clusters of changes in prescribing aripiprazole for bipolar disorder among providers in the VA.

DATA SOURCES

VA administrative data from 2002 to 2010 were used to identify prescriptions of aripiprazole for bipolar disorder. Prescriber characteristics were obtained using the Personnel and Accounting Integrated Database.

STUDY DESIGN

We conducted a retrospective space-time cluster analysis using the space-time permutation statistic.

DATA EXTRACTION METHODS

All VA service users with a diagnosis of bipolar disorder were included in the patient population. Individuals with any schizophrenia spectrum diagnoses were excluded. We also identified all clinicians who wrote a prescription for any bipolar disorder medication.

PRINCIPAL FINDINGS

The study population included 32,630 prescribers. Of these, 8,643 wrote qualifying prescriptions. We identified three clusters of aripiprazole prescribing centered in Massachusetts, Ohio, and the Pacific Northwest. Clusters were associated with prescribing by VA-employed (vs. contracted) prescribers. Nurses with prescribing privileges were more likely to make a prescription for aripiprazole in cluster locations compared with psychiatrists. Primary care physicians were less likely.

CONCLUSIONS

Early prescribing of aripiprazole for bipolar disorder clustered geographically and was associated with prescriber subgroups. These methods support prospective surveillance of practice changes and identification of associated health system characteristics.

摘要

目的

在 VA 中确定精神科医生开具阿立哌唑治疗双相情感障碍处方的时空变化集群。

数据来源

使用 VA 从 2002 年到 2010 年的行政数据来确定阿立哌唑治疗双相情感障碍的处方。使用人员和会计综合数据库获取开处方者的特征。

研究设计

我们使用时空置换统计数据进行了回顾性时空聚类分析。

数据提取方法

将所有患有双相情感障碍诊断的 VA 服务使用者纳入患者人群。排除任何精神分裂症谱系诊断的个体。我们还确定了所有开具任何双相情感障碍药物处方的临床医生。

主要发现

研究人群包括 32630 名开处方者。其中,8643 人开具了合格的处方。我们确定了以马萨诸塞州、俄亥俄州和太平洋西北地区为中心的三个阿立哌唑处方集群。集群与 VA 雇用(而非合同)的开处方者有关。与精神科医生相比,具有处方权限的护士更有可能在集群地点开出阿立哌唑处方。初级保健医生则不太可能。

结论

早期开具阿立哌唑治疗双相情感障碍在地理上呈聚集性,与开处方者亚组有关。这些方法支持对实践变化的前瞻性监测以及相关卫生系统特征的识别。

相似文献

本文引用的文献

10
Medication-use evaluation with a Web application.用药评估的 Web 应用程序。
Am J Health Syst Pharm. 2013 Dec 15;70(24):2226-34. doi: 10.2146/ajhp130252.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验